statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that RLAY's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Relay Therapeutics (RLAY, $8.18) RSI Indicator left the oversold zone on March 27, 2024

Relay Therapeutics (RLAY, $7.8) RSI Indicator left the oversold zone on March 22, 2024

Relay Therapeutics (RLAY, $8.01) RSI Indicator left the oversold zone on March 20, 2024

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY  Get Free Report) have received an average recommendation of Moderate Buy from the ten brokerages that are currently covering the...

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $23.69 Consensus Target Price from Brokerages

Relay Therapeutics, Inc. (NASDAQ:RLAY  Get Free Report)s stock price was down 6.7% on Thursday . The company traded as low as $8.53 and last traded at $8.53. Approximately 55,422 shares...

Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 6.7%

RLAY's total volume now sits at 3.7M. The +-2.69% price change was insignificant, leaving IBM's price at $7.95...

The volume for Relay Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 266% of the 65-Day Volume Moving Average

Relay Therapeutics (RLAY, $8.17) RSI Indicator left the oversold zone on March 14, 2024

This indicator may be signaling that RLAY's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Relay Therapeutics (RLAY, $9.5) entered Downtrend as Momentum indicator drops below 0 level on Mar 11, 2024

This price move could be a signal that RLAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Relay Therapeutics (RLAY, $9.5) price may climb as it broke lower Bollinger Band on Mar 11, 2024

GSA Capital Partners LLP increased its position in Relay Therapeutics, Inc. (NASDAQ:RLAY  Free Report) by 88.8% in the 3rd quarter, according to its most recent disclosure with the Securities...

GSA Capital Partners LLP Purchases 52,712 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Volume	769,165.00
52-Wk High	$13.32
52-Wk Low	$5.78

RLAY Relay Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals